TABLE 4.
Odds ratios with 95% confidence intervals for prevalence of major chronic disease (as elaborated in the supplementary material) among individuals with incident sleep apnoea versus general population (i.e. the total adult population in Finland who used public healthcare services in 2017)
| All, sleep apnoea versus general population | Men, sleep apnoea versus general population | Women, sleep apnoea versus general population | |
| Organic sleep disorders | 8.94 (8.14–9.83) | 6.98 (6.03–8.07) | 8.27 (7.10–9.63) |
| Obesity | 7.19 (6.87–7.53) | 7.70 (7.22–8.22) | 8.57 (8.03–9.15) |
| COPD | 3.17 (2.96–3.39) | 2.35 (2.16–2.55) | 4.23 (3.76–4.76) |
| Other respiratory disease | 2.73 (2.63–2.84) | 2.78 (2.64–2.93) | 3.11 (2.93–3.30) |
| Diabetes | 2.72 (2.64–2.81) | 2.37 (2.28–2.46) | 2.96 (2.80–3.12) |
| Other metabolic disease | 2.67 (2.51–2.84) | 2.43 (2.32–2.54) | 3.16 (2.90–3.44) |
| Hypertension | 2.65 (2.57–2.72) | 2.58 (2.49–2.68) | 2.92 (2.79–3.05) |
| Asthma | 2.62 (2.51–2.74) | 2.43 (2.28–2.60) | 3.49 (3.28–3.72) |
| Gastro-oesophageal reflux disease | 2.53 (2.34–2.74) | 2.22 (1.98–2.49) | 3.34 (2.99–3.73) |
| Nonorganic sleep disorders | 2.45 (2.27–2.64) | 2.42 (2.17–2.69) | 2.93 (2.63–3.27) |
| Heart failure | 2.42 (2.26–2.58) | 2.56 (2.36–2.78) | 2.23 (2.00–2.50) |
| Dyslipidaemia | 2.39 (2.30–2.49) | 2.31 (2.20–2.43) | 2.47 (2.31–2.64) |
| Kidney and urinary tract disease | 2.25 (2.09–2.42) | 1.89 (1.74–2.06) | 2.39 (2.10–2.73) |
| Cardiovascular disease | 2.09 (2.03–2.15) | 1.45 (1.33–1.58) | 1.93 (1.71–2.16) |
| Atrial fibrillation | 2.04 (1.95–2.13) | 1.91 (1.81–2.02) | 1.91 (1.76–2.07) |
| Urogenital disease | 2.03 (1.93–2.13) | 1.57 (1.49–1.66) | 1.59 (1.39–1.83) |
| Musculoskeletal disorders | 1.98 (1.93–2.03) | 1.94 (1.88–2.00) | 2.59 (2.48–2.70) |
| Mood and neurotic disorders | 1.79 (1.73–1.86) | 1.74 (1.65–1.84) | 2.33 (2.21–2.45) |
| Neurological disorders | 1.69 (1.62–1.76) | 1.65 (1.56–1.75) | 2.12 (1.99–2.25) |
| Cerebrovascular disease | 1.69 (1.58–1.81) | 1.45 (1.33–1.58) | 1.93 (1.71–2.16) |
| Thyroid disease | 1.64 (1.54–1.73) | 1.89 (1.70–2.11) | 2.34 (2.18–2.51) |
| Gastrointestinal disease | 1.58 (1.53–1.63) | 1.51 (1.44–1.57) | 1.87 (1.78–1.97) |
| Cancer | 1.14 (1.08–1.21) | 1.02 (0.96–1.10) | 1.29 (1.19–1.41) |
| Glaucoma | 1.12 (1.02–1.24) | 1.11 (0.98–1.27) | 1.29 (1.12–1.48) |
| Schizophrenia and delusional disorders | 1.10 (0.99–1.22) | 0.90 (0.79–1.04) | 1.36 (1.15–1.60) |
| Dementia and other cerebral disorders | 0.92 (0.87–0.98) | 0.87 (0.80–0.93) | 0.86 (0.77–0.97) |